Go to the profile of Cold Genesys

Cold Genesys

  • (657) 258-1260
  • Networkers
  • United States of America

About Cold Genesys

Cold Genesys in a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies. Our strategy is centered on providing patients with new and impactful therapies. Our lead proprietary agent, CG0070, has the potential to deliver safe and effective cancer care alone and in combination with other immunotherapies. CG0070 has been shown to be a safe agent in BCG-failure non-muscle invasive bladder cancer (NMIBC) and we are exploring further types of cancer in clinical studies. We aim to take the next evolutionary step in delivering innovative cancer care to millions of patients in need worldwide.

Therapeutic Areas




Company Type

Biotechnology – Therapeutics

State of Ownership


Sponsorship Group


Influencer Of


Editions participated in:

September 2018